This study evaluates the accessory anti-tumor effect of adlay processing food (APF) on animals. Experimental diets containing amounts of APF were fed to ICR male mice during a subcutaneously injection of Sarcoma-180 tumor cells. The accessory anti-tumor effect was determined by the tumor weight, transplantation speed of tumor cells, and mean survival time. The tumor weights of the test group fed with the diets containing APF levels of 9%, 18% and 36% were significantly lighter than the tumor weights of the control group (p< 0.05). In the test group (APF 18%) tumor cell transfer was undiscovered after 60 feeding days. However, 25% of in the control group on day 45 and 50% on day 60 were discovered to have transferred to the lung. The mean survival time of the test group (106.5 days) was significantly longer than the control group (77 days). The results indicate that APF has an accessory anti-tumor effect, and the recommended daily intake is approximately 2.85 g/kg for cancer patients.
This study evaluates the accessory anti-tumor effect of adlay processing food (APF) on animals. Experimental diets containing amounts of APF were fed to ICR male mice during a subcutaneously injection of Sarcoma-180 tumor cells. The accessory anti-tumor effect was determined by the tumor weight, transplantation speed of tumor cells, and mean survival time. The tumor weights of the test group fed with the diets containing APF levels of 9%, 18% and 36% were significantly lighter than the tumor weights of the control group (p< 0.05). In the test group (APF 18%) tumor cell transfer was undiscovered after 60 feeding days. However, 25% of in the control group on day 45 and 50% on day 60 were discovered to have transferred to the lung. The mean survival time of the test group (106.5 days) was significantly longer than the control group (77 days). The results indicate that APF has an accessory anti-tumor effect, and the recommended daily intake is approximately 2.85 g/kg for cancer patients.